7Baggers
 Xencor (NASDAQ:XNCR) Shares Up 8.7% - What's Next?  MarketBeat Wed, 12 Nov 2025 22:24:19 GMT
 Xencor at TD Cowen Summit: Strategic Focus on Oncology and Autoimmune  Investing.com Nigeria Wed, 12 Nov 2025 22:13:30 GMT
 xencor shares signal potential biotech revival  AD HOC NEWS Tue, 11 Nov 2025 10:27:04 GMT
 Xencor to Participate at Upcoming Investor Conferences  Business Wire Mon, 10 Nov 2025 21:01:00 GMT
 Cantor Fitzgerald Predicts Increased Earnings for Xencor  MarketBeat Mon, 10 Nov 2025 06:22:59 GMT
 Wedbush Estimates Xencor's FY2025 Earnings (NASDAQ:XNCR)  MarketBeat Mon, 10 Nov 2025 06:22:52 GMT
 FY2025 Earnings Estimate for Xencor Issued By William Blair  MarketBeat Mon, 10 Nov 2025 06:22:49 GMT
 Leerink Partnrs Increases Earnings Estimates for Xencor  MarketBeat Mon, 10 Nov 2025 06:22:47 GMT
 published on: 2025-11-09 23:13:10  newser.com Mon, 10 Nov 2025 05:13:10 GMT
 Wedbush Reaffirms "Outperform" Rating for Xencor (NASDAQ:XNCR)  MarketBeat Fri, 07 Nov 2025 18:41:49 GMT
 Xencor (XNCR) Gets a Hold from Bank of America Securities  The Globe and Mail Fri, 07 Nov 2025 08:00:00 GMT
 Xencor (XNCR) Analyst Rating Update: RBC Capital Raises Price Ta  GuruFocus Thu, 06 Nov 2025 18:56:15 GMT
 xencor price target lowered to $18 from $20 at jpmorgan  TipRanks Thu, 06 Nov 2025 14:05:33 GMT
 Xencor Reports Improved Q3 2025 Financial Results  TipRanks Thu, 06 Nov 2025 05:38:18 GMT
 Decoding Xencor Inc (XNCR): A Strategic SWOT Insight  GuruFocus Thu, 06 Nov 2025 05:33:49 GMT
 xencor inc earnings beat by $0.61, revenue fell short of estimates  Investing.com Canada Thu, 06 Nov 2025 02:37:59 GMT
 xencor reports q3 eps (8c), consensus (70c)  TipRanks Wed, 05 Nov 2025 21:58:00 GMT
 Xencor Reports Third Quarter 2025 Financial Results  Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
 Xencor (XNCR) Reports Q3 Loss, Misses Revenue Estimates  Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
 Xencor: Q3 Earnings Snapshot  San Antonio Express-News Wed, 05 Nov 2025 08:00:00 GMT
 Xencor Inc earnings beat by $0.61, revenue fell short of estimates  Investing.com Wed, 05 Nov 2025 08:00:00 GMT
 antibody developer xencor misses q3 revenue estimates, net loss narrows  MarketScreener Wed, 05 Nov 2025 08:00:00 GMT

Xencor, Inc
(NASDAQ:XNCR) 

XNCR stock logo

Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases in the United states and internationally. The company's product candidates include Obex...

Founded: 1997
Full Time Employees: 166
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends